Efficiency of second pegylated interferon and ribavirin combination treatment for the relapsed hepatitis C virus infection in low-income countries

Basit Öğe Kaydı
dc.contributor.authorCeylan, Bahadır
dc.contributor.authorAslan, Ferhat
dc.contributor.authorYardımcı, Cem
dc.contributor.authorFincancı, Muzaffer
dc.contributor.authorÖzgüneş, Nail
dc.date.accessioned10.07.201910:49:13
dc.date.accessioned2019-07-10T19:52:29Z
dc.date.available10.07.201910:49:13
dc.date.available2019-07-10T19:52:29Z
dc.date.issued2014
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Ana Bilim Dalı
dc.descriptionWOS: 000332604700021
dc.descriptionPubMed ID: 24598385
dc.description.abstractThe current treatment for chronic hepatitis C virus (HCV) infection in Turkey is pegylated interferon (IFN) plus ribavirin combination. Patients who developed relapse following the first pegylated IFN plus ribavirin combination treatment are recommended to be treated by regimes in which protease inhibitors are combined with pegylated IFN plus ribavirin [1,2].
dc.identifier.citationCeylan, B., Aslan, F., Yardımcı, C., Fincancı, M. ve Özgüneş, N. (2014). Efficiency of second pegylated interferon and ribavirin combination treatment for the relapsed hepatitis C virus infection in low-income countries. European Journal of Gastroenterology & Hepatology, 26(4), 493-494. https://dx.doi.org/10.1097/MEG.0000000000000054
dc.identifier.doi10.1097/MEG.0000000000000054
dc.identifier.endpage494
dc.identifier.issn0954-691X
dc.identifier.issn1473-5687
dc.identifier.issue4
dc.identifier.scopusqualityQ2
dc.identifier.startpage493
dc.identifier.urihttps://dx.doi.org/10.1097/MEG.0000000000000054
dc.identifier.urihttps://hdl.handle.net/20.500.12511/2409
dc.identifier.volume26
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherLippincott Williams & Wilkins
dc.relation.ispartofEuropean Journal of Gastroenterology & Hepatologyen_US
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/embargoedAccess
dc.subjectPegylated Interferon
dc.subjectRibavirin Combination Treatment
dc.subjectHepatitis C Virus
dc.titleEfficiency of second pegylated interferon and ribavirin combination treatment for the relapsed hepatitis C virus infection in low-income countries
dc.typeLetter

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
Aslan, Ferhat-2014.pdf
Boyut:
96.24 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
Diğer Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu